NovaBay Pharmaceuticals, Inc. (NYSE American: NBY), to be renamed Stablecoin Development Corporation (NYSE American: SDEV), is an on-chain holding company focused on long-duration participation in protocol-aligned digital asset ecosystems. The Company's common stock is expected to begin trading on the NYSE American under the ticker symbol SDEV on April 3, 2026. In 2026, the Company completed a comprehensive realignment of its business, adopting a capital allocation approach focused on acquiring and holding economically productive digital assets that enable participation in open, decentralized financial networks. The Company's core business consists of the accumulation, holding, and deployment of operating digital assets for use within blockchain-based networks to support protocol-level services, including staking, governance participation, and related activities. The Company's initial focus is SKY, the protocol token of the decentralized Sky Protocol. In January 2026, the Company completed a ~$134 million private placement with R01 Fund LP, Framework Ventures, Tether Investments, and Sky Frontier Foundation, consisting of cash, stablecoins, and SKY tokens. The Company continues to deploy capital toward the acquisition of additional SKY tokens on the open market. Headquartered in Emeryville, California. Committed to prudent governance, regulatory compliance, and long-term shareholder value creation. For more information, visit www.novabay.com.
We're tracking NovaBay Pharmaceuticals's market expansion
How NovaBay Pharmaceuticals's international expansion compares to its competitors
NovaBay PharmaceuticalsYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 NovaBay PharmaceuticalsYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
NovaBay Pharmaceuticals reminds shareholders about pending special dividend and upcoming 2025 Annual Meeting, emphasizing important information.
NovaBay Pharmaceuticals rebrands as Stablecoin Development Corporation, acquires 2.06 billion SKY tokens, representing 8.78% of total supply.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about NovaBay Pharmaceuticals's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
